Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Novel Tacrine-Based Pyrano[3’,4’:5,6]Pyrano[2,3-B]Quinolinones: Synthesis and Cholinesterase Inhibitory Activity Publisher Pubmed



Hariri R1 ; Afshar Z1 ; Mahdavi M2 ; Safavi M3 ; Saeedi M4, 5 ; Najafi Z6 ; Sabourian R5 ; Karimpourrazkenari E5 ; Edraki N7 ; Moghadam FH8 ; Shafiee A1 ; Khanavi M9 ; Akbarzadeh T1, 5
Authors
Show Affiliations
Authors Affiliations
  1. 1. Faculty of Pharmacy, Department of Medicinal Chemistry, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Drug Design and Development Research Center, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Department of Biotechnology, Iranian Research Organization for Science and Technology, Tehran, Iran
  4. 4. Medicinal Plants Research Center, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
  5. 5. Persian Medicine and Pharmacy Research Center, Tehran University of Medical Sciences, Tehran, Iran
  6. 6. Faculty of Pharmacy, Department of Medicinal Chemistry, Hamadan University of Medical Sciences, Hamadan, Iran
  7. 7. Medicinal and Natural Products Chemistry Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
  8. 8. Department of Cellular Biotechnology at Cell Science Research Center, Royan Institute for Biotechnology, ACECR, Isfahan, Iran
  9. 9. Faculty of Pharmacy, Department of Pharmacognosy, Tehran University of Medical Sciences, Tehran, Iran

Source: Archiv der Pharmazie Published:2016


Abstract

In order to develop effective anti-cholinesterase compounds, a novel series of pyrano[3’,4’:5,6]pyrano[2,3-b]quinolinones were designed, synthesized, and evaluated in vitro against acetylcholinesterase (AChE) and butyrylcholinesterase (BChE). All derivatives showed very good AChE inhibitory (AChEI) activity (IC50 = 0.37–5.62 μM) compared with rivastigmine (IC50 = 11.07 μM). Among them, 11-amino-12-(2,3-dichlorophenyl)-3-methyl-7,8,9,10-tetrahydropyrano[3’,4’:5,6]pyrano[2,3-b]quinolin-1(12H)-one (6f) displayed the best inhibitory activity. However, most of the synthesized compounds showed no anti-BChE activity and compounds 6b and 6f were found to be only moderate inhibitors. The most potent anti-AChE compound 6f had low and moderate inhibitory activity and neuroprotective effects against beta-secretase (BACE1) and oxidative stress-induced cell death, respectively. Also, kinetic and molecular docking studies of binding interactions elucidated that compound 6f bound to both the catalytic anionic site (CAS) and peripheral anionic site (PAS) of AChE. © 2016 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim